title: Fusion in the ETS gene family and prostate cancer.
abstract: It has recently been shown that the majority of prostate cancers harbour a chromosomal rearrangement that fuses the gene for an androgen-regulated prostate-specific serine protease, TMPRSS2, with a member of the ETS family of transcription factors, most commonly ERG. These are among the most common genetic alterations in any human solid tumour. This knowledge may provide us with clues to prostate carcinogenesis, and may lead to the development of important molecular-based biomarkers for patients with localised prostate cancer. The most common variant is fusion between the 5'-untranslated region of TMPRSS2 and the 3' region of ERG. However, over 20 other fusion variants have now been described (involving over 10 different genes) and the number of variants continues to grow. Fusion products can be identified by several techniques, including FISH, RT-PCR, and expression profiling using exon arrays. The protein products associated with the fusion transcripts have not been characterised, and the phenotypic expression of the various products of gene fusion on prostate cancer histology, or on the clinical course of cancer, are not yet understood. Several early cohort studies suggest that the presence of the TMPRSS2:ERG fusion product is associated with relatively poor cancer-specific survival. Studies that examine how individual variants and their associated phenotypes affect prostate cancer presentation and progression are required.
authors.affiliation: Department of Medicine, Womens College Research Institute, University of Toronto, ON, Canada. steven.narod@wchospital.ca
authors.forename: S A
authors.initials: SA
authors.lastname: Narod
authors.forename: A
authors.initials: A
authors.lastname: Seth
authors.forename: R
authors.initials: R
authors.lastname: Nam
mesh_terms: D006801:Humans; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics* / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology; D050783:Proto-Oncogene Proteins c-ets / Q000235:genetics*; D012697:Serine Endopeptidases / Q000235:genetics*
chemical_list: D015514:Oncogene Proteins, Fusion; D050783:Proto-Oncogene Proteins c-ets; D012697:Serine Endopeptidases; C421305:TMPRSS2 protein, human
references.citation: Oncogene. 2007 Apr 19;26(18):2667-73
references.pmid: 17043636
references.citation: Mod Pathol. 2007 May;20(5):538-44
references.pmid: 17334343
references.citation: Cancer Res. 2007 Sep 1;67(17):7991-5
references.pmid: 17804708
references.citation: J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33
references.pmid: 17925536
references.citation: Cancer Res. 2001 Feb 15;61(4):1686-92
references.pmid: 11245484
references.citation: Neoplasia. 2006 Jun;8(6):465-9
references.pmid: 16820092
references.citation: Br J Cancer. 2007 Dec 17;97(12):1690-5
references.pmid: 17971772
references.citation: Cancer Res. 2006 Nov 1;66(21):10242-6
references.pmid: 17079440
references.citation: Mod Pathol. 2007 Apr;20(4):467-73
references.pmid: 17334351
references.citation: Science. 2005 Oct 28;310(5748):644-8
references.pmid: 16254181
references.citation: Cancer Res. 2008 Jan 1;68(1):73-80
references.pmid: 18172298
references.citation: Genes Chromosomes Cancer. 2007 Nov;46(11):972-80
references.pmid: 17654723
references.citation: Cancer Res. 2006 Sep 1;66(17):8337-41
references.pmid: 16951139
references.citation: J Natl Cancer Inst. 2005 Jan 19;97(2):103-15
references.pmid: 15657340
references.citation: Oncogene. 2005 May 26;24(23):3847-52
references.pmid: 15750627
references.citation: Mod Pathol. 2007 Sep;20(9):921-8
references.pmid: 17632455
references.citation: Cancer Res. 2006 Sep 1;66(17):8347-51
references.pmid: 16951141
references.citation: Urology. 2007 Oct;70(4):630-3
references.pmid: 17991527
references.citation: Cancer Res. 2006 Apr 1;66(7):3396-400
references.pmid: 16585160
references.citation: Nat Genet. 2007 May;39(5):645-9
references.pmid: 17401363
references.citation: Cancer Biol Ther. 2007 Jan;6(1):40-5
references.pmid: 17172822
references.citation: Oncogene. 2007 Jul 5;26(31):4596-9
references.pmid: 17237811
references.citation: Cancer Res. 2006 Nov 15;66(22):10658-63
references.pmid: 17108102
references.citation: Clin Cancer Res. 2007 Sep 1;13(17):5103-8
references.pmid: 17785564
references.citation: Nature. 2007 Aug 2;448(7153):595-9
references.pmid: 17671502
references.citation: Eur J Cancer. 2005 Nov;41(16):2462-78
references.pmid: 16213704
references.citation: Genes Chromosomes Cancer. 2006 Jul;45(7):717-9
references.pmid: 16575875
references.citation: J Clin Pathol. 2007 Nov;60(11):1238-43
references.pmid: 17259299
references.citation: Mol Endocrinol. 2007 Aug;21(8):1835-46
references.pmid: 17505060
references.citation: Cancer Res. 2008 May 1;68(9):3094-8
references.pmid: 18451133
references.citation: Oncogene. 2008 Jan 10;27(3):253-63
references.pmid: 17637754
references.citation: Nat Genet. 2006 Jun;38(6):652-8
references.pmid: 16682969
references.citation: J Pathol. 2007 May;212(1):91-101
references.pmid: 17385188